James C. Hamilton
Chief Medical Officer · ARROWHEAD PHARMACEUTICALS, INC.
- 2025
- Apr 24, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies James C. Hamilton files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Richard Anzalone - $12.35M in ARWR purchases and sales in the last 12 months
- Michael S. Perry - $1.01M in ARWR purchases and sales in the last 12 months
- Daniel Joseph Apel - $934K in ARWR purchases and sales in the last 12 months
- Mauro Ferrari - $493K in ARWR purchases and sales in the last 12 months
- Hongbo Lu - $228K in ARWR purchases and sales in the last 12 months
- Adeoye Y. Olukotun - $174K in ARWR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is James C. Hamilton?
James C. Hamilton is a corporate insider, tracked as Chief Medical Officer of ARROWHEAD PHARMACEUTICALS, INC. (ARWR). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did James C. Hamilton last file a Form 4?
The most recent primary Form 4 on record is dated 24 April 2026, one of 6 filings going back to 2025.
Has James C. Hamilton been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($3.12M) across all tracked filings.
